CClinicalTrials.gg
CompletedNCT03941145Updated Mar 24, 2020

Effectiveness of a Novel Workplace-based Exercise Intervention: a Pilot Study

An interventional study of Reduced-Exertion High-Intensity Interval Training (REHIT) in Health Behavior, sponsored by University of Stirling. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-03-24.

Sponsored by University of Stirling · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Sufficient physical activity and a good cardiorespiratory fitness level (CRF) are central in cardiovascular disease (CVD) risk reduction. However, many people remain inactive, partly because current exercise recommendations fail to address important barriers to exercise. A novel exercise protocol has previously been developed called 'reduced-exertion high-intensity interval training' (REHIT), which can remove several common perceived barriers to exercise. REHIT 1) improves CRF and other key CVD risk factors, 2) is genuinely time-efficient (total time-commitment of just 2x10 min per week), 3) is well-tolerated, manageable, and not associated with negative affective responses, and 4) can be done in the workplace, in work-clothes and without a need to shower afterwards. To date, this intervention has only been investigated in a lab-setting. Therefore, in the present randomised controlled trial, the 'real-world' effectiveness of REHIT in improving maximal aerobic capacity (V̇O2max; a key risk factors of CVD) will be investigated in a workplace setting. Participants' attitudes and psychological responses to REHIT will be assessed to evaluate the likelihood of successful implementation. In 2 study centres, a total of up to n=50 physically inactive male and female office workers will be recruited to perform 6 weeks of unsupervised, computer-guided, office-based REHIT (n=25) or act as a control (n=25).

02

Conditions studied

  • Health Behavior

Keywords

  • exercise
03

In context

Lead sponsor

University of Stirling is the lead sponsor of 23 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Employee at participating workplace

Exclusion criteria

Exclusion Criteria:

  • Aged \< 18 years or > 60 years
  • History of type 2 diabetes
  • Insulin therapy
  • Use of β-blockers
  • Use of inhaled steroids (e.g. for asthma)
  • Any cardiovascular condition with the exception of well-controlled uncomplicated hypertension (systolic >140 mm Hg and/or >90 mm Hg after at least 5 minutes of seated rest), which is treated with no more than two drugs (either an ACE, ARB, calcium channel blocker, or diuretic)
  • Cerebrovascular disease including previous stroke or aneurysm
  • History of exercise-induced asthma
  • History of type 1 diabetes mellitus or a history of ketoacidosis
  • History of other specific types of diabetes (e.g., genetic syndromes, secondary pancreatic diabetes, diabetes due to endocrinopathies, drug or chemical-induced, and post organ transplant)
  • History of respiratory disease including pulmonary hypertension or chronic obstructive pulmonary disease
  • History of musculoskeletal or neurological disorders
  • Active inflammatory bowel disease
  • History of renal disease
  • Other metabolic diseases, including hyper/ hypo-parathyroidism, hyper/hypo-thyroidism, and Cushing's disease.
  • BMI>35 kg/m2
  • A clinically significant resting ECG abnormality at the pre-screening visit which in the opinion of the cardiologist exposes the participant to risk by take part in the main trial.
  • 'Yes' to any questions on a standard physical activity readiness questionnaire (PARQ)
  • Classification as moderately or highly physically active on the International Physical Activity Questionnaire (IPAQ)
  • Current participation in another research study
  • Inability to fully understand the verbal and written descriptions of the study in English, and the instructions provided during the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    Exercise

    Participants allocated to the intervention group will be asked to perform 2 exercise sessions per week for 6 weeks. Each session will involve 10 min of low-intensity cycling (25 W) interspersed with two 20-s 'all-out' cycle sprints against a resistance equivalent to 5% of body mass. The exercise intervention will be delivered on a commercially available cycle ergometer with software developed by CAR.O.L.

    Behavioral: Reduced-Exertion High-Intensity Interval Training (REHIT)

  • No intervention
    Control

    The effects of the intervention will be compared to a no-intervention control group recruited from the same workplace settings.

Interventions

  • BehavioralReduced-Exertion High-Intensity Interval Training (REHIT)

    REHIT is a type of Sprint Interval Training (SIT) that has been shown to be efficacious at improving maximal aerobic capacity using a minimal volume of exercise.

06

What researchers measure

Primary outcomes

  1. Change in maximal aerobic capacity

    Aerobic capacity: a key risk factor of noncommunicable disease

    Time frame: Change from baseline to 3 days after the 6-week intervention

Secondary outcomes

  1. Change in motivation for exercise

    Motivation to exercise as assessed using the RM 4-FM questionnaire, a 16-item questionnaire assessing reasons for trying to be physically active on a scale from 1 ('not at all true') to 7 ('very true'). Higher scores indicate a greater motivation for performing exercise. Scores are added to get an overall score, with higher overall scores indicating greater intrinsic motivation.

    Time frame: Change from baseline to 3 days after the 6-week intervention

  2. Change in health status

    Health status as assessed using the Short Form (36) Health Survey (SF36), which is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

    Time frame: Change from baseline to 3 days after the 6-week intervention

  3. Change in perceived stress

    Perceived stress as assessed using the Perceived Stress Scale questionnaire, which measures the degree to which situations in one's life are appraised as stressful. The 10-item questionnaire ask for the frequency of stressful events in the last month, scored on a scale from 0 ('never') to 4 ('very often'). The sum score is taken, with higher scores indicating more perceived stress.

    Time frame: Change from baseline to 3 days after the 6-week intervention

  4. Intervention acceptability

    Intervention acceptability as assessed using a questionnaire published by Boereboom et al (2016). This 11-item questionnaire asks how strongly participants agree with statements on the acceptability of the exercise intervention on a scale from 1 ('strongly disagree') to 5 ('strongly agree').

    Time frame: 3 days after the 6-week intervention

07

Study locations

1 site
  • Stirling Council
    Stirling, FK49LA, United Kingdom
08

References and documents

Publications

  • Metcalfe RS, Atef H, Mackintosh K, McNarry M, Ryde G, Hill DM, Vollaard NBJ. Time-efficient and computer-guided sprint interval exercise training for improving health in the workplace: a randomised mixed-methods feasibility study in office-based employees. BMC Public Health. 2020 Mar 12;20(1):313. doi: 10.1186/s12889-020-8444-z. PubMed 32164631 ↗

Individual participant data

Plan to share: No — data will be disseminated / published as means +- SD. no individual data will be presented.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03941145
Lead sponsor
University of Stirling
Collaborators
Swansea University
Responsible party
Niels Vollaard (Principal Investigator, University of Stirling) — Principal investigator
First posted
May 7, 2019
Start date
May 1, 2019
Primary completion
Sep 13, 2019
Completion
Nov 13, 2019
Last update
Mar 24, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion